Aurobindo to turn out lights at troubled NJ plant, putting 99 jobs on the chopping block
March 23, 2022Novartis’ radiotherapy Pluvicto nabs FDA approval for prostate cancer, with $2B-plus peak sales expectations
March 24, 2022Novartis’ Sandoz, following Pfizer’s lead, launches 2nd carcinogen-related drug recall this week
fkansteiner
Wed, 03/23/2022 – 14:55
